One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Application Prospects of in Vitro Diagnostic TechnologyMarch 9, 2023The development of in vitro diagnostic (IVD) technologies has been rapid, spanning from genetic sequencing, SNP screening, point mutation gene diagnosis at the gene level, to the detection of various ...view
What Is Fetal Chromosomal Aneuploidy Test?April 8, 2024Fetal chromosomal aneuploidy testing analyzes a developing baby's chromosomes to identify any abnormal numbers. Chromosomes are the thread-like structures within cells that carry our genetic infor...view
What Are the Diagnostic Methods for Breast Cancer?April 4, 2023Breast cancer has become a terrifying disease that kills female friends with increasing clinical incidence rate. It not only harms women's health but also has a great impact on our normal life. So...view